TerminatedNCT02351869
Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolarity
Medication studyAges 20–60Canada
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 20 years to 60 years. Other eligibility criteria apply.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateAugust 2015
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 25
- Sponsor
- Sunnybrook Health Sciences Centre
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 20 Years to 60 Years
- Official registry ID
- NCT02351869
- Official title
Show the full official title
Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolar Disorder
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sunnybrook Health Sciences Centre.
Does this study involve medication?
Yes. The study involves medication, including Nitrous Oxide and Midazolam.
Who can participate?
This study is for people with bipolarity. Listed age limits: 20 years to 60 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
